Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?
Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Is Boyd Gaming (BYD) Stock Undervalued Right Now?
Is Boyd Gaming (BYD) Stock Undervalued Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Why Axis Capital (AXS) is a Top Value Stock for the Long-Term
Why Axis Capital (AXS) is a Top Value Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Should Value Investors Buy Carnival (CCL) Stock?
Should Value Investors Buy Carnival (CCL) Stock?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Here's Why Carnival (CCL) is a Strong Value Stock
Here's Why Carnival (CCL) is a Strong Value Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Should Value Investors Buy Vinci (VCISY) Stock?
Should Value Investors Buy Vinci (VCISY) Stock?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

Are Medical Stocks Lagging  Akebia Therapeutics (AKBA) This Year?Photo, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Are Medical Stocks Lagging Akebia Therapeutics (AKBA) This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Akebia Therapeutics (AKBA) one of those stocks right now? A quick glance at the

Is Align Technology (ALGN) Stock Undervalued Right Now?
Is Align Technology (ALGN) Stock Undervalued Right Now?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

Is ANET Stock a Strong Buy Ahead of Q2 Earnings Release?
Is ANET Stock a Strong Buy Ahead of Q2 Earnings Release?

Arista Networks, Inc. ANET is scheduled to report second-quarter 2025 earnings on Aug. 5. The Zacks Consensus Estimate for revenues and earnings is pegged at $2.11 billion and 65 cents per share

The Zacks Analyst Blog Highlights Costco Wholesale, HSBC, Booking and Smith-Midland
The Zacks Analyst Blog Highlights Costco Wholesale, HSBC, Booking and Smith-Midland

For Immediate Release

Chicago, IL – August 1, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Align Technology (ALGN) Loses 34.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Align Technology (ALGN) Loses 34.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Align Technology (ALGN) has been beaten down lately with too much selling pressure. While the stock has lost 34.5% over the past four weeks, there is light at the end of the tunnel as it is now in

Check Point (CHKP) Loses 16.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerPhoto, wide shot, wide-angle lens,  Consumer electronics manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.theapi.app/temp/d8a4268f-c982-4aa8-a09e-f9ee1db62f57.png
Check Point (CHKP) Loses 16.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

A downtrend has been apparent in Check Point Software (CHKP) lately with too much selling pressure. The stock has declined 16.7% over the past four weeks. However, given the fact that it is now in

Down 7.1% in 4 Weeks, Here's Why Adtalem (ATGE) Looks Ripe for a Turnaround
Down 7.1% in 4 Weeks, Here's Why Adtalem (ATGE) Looks Ripe for a Turnaround

Adtalem Global Education (ATGE) has been beaten down lately with too much selling pressure. While the stock has lost 7.1% over the past four weeks, there is light at the end of the tunnel as it is

Insight Enterprises (NSIT) Loses 17.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Insight Enterprises (NSIT) Loses 17.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Insight Enterprises (NSIT) has been on a downward spiral lately with significant selling pressure. After declining 17.6% over the past four weeks, the stock looks well positioned for a trend

Ocugen (OCGN) Reports Q2 Loss, Misses Revenue Estimates
Ocugen (OCGN) Reports Q2 Loss, Misses Revenue Estimates

Ocugen (OCGN) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.04 per share a year ago. These figures are

After Plunging 15.4% in 4 Weeks, Here's Why the Trend Might Reverse for Gartner (IT)
After Plunging 15.4% in 4 Weeks, Here's Why the Trend Might Reverse for Gartner (IT)

Gartner (IT) has been beaten down lately with too much selling pressure. While the stock has lost 15.4% over the past four weeks, there is light at the end of the tunnel as it is now in oversold

Ameren Q2 Earnings Higher Than Expected, Revenues Increase Y/Y
Ameren Q2 Earnings Higher Than Expected, Revenues Increase Y/Y

Ameren Corporation AEE reported second-quarter 2025 earnings of $1.01 per share, which beat the Zacks Consensus Estimate of $1 by 1%. The bottom line also improved 4.1% from the year-ago quarter’s

LyondellBasell's Earnings Lag Estimates, Revenues Beat in Q2
LyondellBasell's Earnings Lag Estimates, Revenues Beat in Q2

LyondellBasell Industries N.V. LYB recorded a second-quarter 2025 profit of $115 million or 34 cents per share, reflecting a decrease of 87.5% from $924 million or $2.82 per share reported a year

Compared to Estimates, Church & Dwight (CHD) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Church & Dwight (CHD) Q2 Earnings: A Look at Key Metrics

Church & Dwight (CHD) reported $1.51 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 0.3%. EPS of $0.94 for the same period compares to $0.93 a year ago.

Compared to Estimates, Colgate-Palmolive (CL) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Colgate-Palmolive (CL) Q2 Earnings: A Look at Key Metrics

Colgate-Palmolive (CL) reported $5.11 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 1%. EPS of $0.92 for the same period compares to $0.91 a year ago.

Here's What Key Metrics Tell Us About Credit Acceptance (CACC) Q2 Earnings
Here's What Key Metrics Tell Us About Credit Acceptance (CACC) Q2 Earnings

Credit Acceptance (CACC) reported $583.8 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 8.5%. EPS of $8.56 for the same period compares to -$3.83 a

Telus (TU) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Telus (TU) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, Telus (TU) reported revenue of $3.67 billion, up 1% over the same period last year. EPS came in at $0.16, compared to $0.18 in the year-ago quarter.

The reported

CBOE (CBOE) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
CBOE (CBOE) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

CBOE Global (CBOE) reported $587.3 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 14.3%. EPS of $2.46 for the same period compares to $2.15 a year ago.

Here's What Key Metrics Tell Us About nVent (NVT) Q2 Earnings
Here's What Key Metrics Tell Us About nVent (NVT) Q2 Earnings

nVent Electric (NVT) reported $963.1 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 9.4%. EPS of $0.86 for the same period compares to $0.82 a year

Avantor (AVTR) Reports Q2 Earnings: What Key Metrics Have to Say
Avantor (AVTR) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Avantor, Inc. (AVTR) reported revenue of $1.68 billion, down 1.1% over the same period last year. EPS came in at $0.24, compared to $0.25 in the year-ago quarter.